Lélia Delamarre

8PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Chemical and thermal processes in energy and combustionSemi- and unsupervised learningMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 21, 2024
Vax-Innate: improving therapeutic cancer vaccines by modulating T cells and the tumour microenvironment.

Faezzah Baharom, Dalton Hermans, Lélia Delamarre

|Mar 15, 2024
The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity.

Junghyun Lim, Ryan Rodriguez, Katherine Williams

|Dec 14, 2023
Nucleotide modifications enable rational design of TLR7-selective ligands by blocking RNase cleavage.

Ann-Jay Tong, Rebecca Leylek, Anna-Maria Herzner

|Sep 09, 2022
Sources of Cancer Neoantigens beyond Single-Nucleotide Variants.

Aude-Hélène Capietto, Reyhane Hoshyar, Lélia Delamarre

|Mar 22, 2021
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion.

Suchit Jhunjhunwala, Christian Hammer, Lélia Delamarre

|Sep 14, 2020
Dexamethasone premedication suppresses vaccine-induced immune responses against cancer.

Mathias Vormehr, Sophie Lehar, Lena M Kranz

Pageof 2

Frequent Collaborators

3 joint publications

Aude-Hélène Capietto

2 joint publications

Suchit Jhunjhunwala

2 joint publications

Faezzah Baharom

2 joint publications

Ira Mellman